Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1069 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-01-26 (simplywall.st)
We Think Charles River Laboratories International (NYSE:CRL) Is Taking Some Risk With Its Debt - Simply Wall St News
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Read more
2024-07-26 (simplywall.st)
Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Read more
2023-06-12 (globenewswire.com)
Long-Term Investors of CRL, FIS, GL, NSC Alert: Johnson Fistel, LLP Encourages Investors to Submit Their Information Below
SAN DIEGO, June 12, 2023 (GLOBE NEWSWIRE) -- Charles River Laboratories International, Inc. Johnson Fistel, LLP is investigating potential claims on...
Read more
2023-04-19 (globenewswire.com)
Investigation Alert CRL, FIS, GL, NSC: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
SAN DIEGO, April 19, 2023 (GLOBE NEWSWIRE) -- Charles River Laboratories International, Inc. Johnson Fistel, LLP is investigating potential...
Read more
2010-04-26 (massdevice.com)
Charles River Labs to pay $1.6 billion for WuXi PharmaTech
Charles River Laboratories International Inc. (NYSE:CRL) didn’t let disappointing first-quarter results slow it down, inking a $1.6 billion cash-and-stock deal to acquire Shanghai-based WuXi PharmaTech (Cayman) Inc. (NYSE:WX). The Winchester,
Read more